Valeant Pharmaceuticals International, Inc., November 16, 2016
November 16, 2016
A consortium of law firms has been formed between counsel in the various Ontario actions. The Ontario action has been consolidated with the other action filed against Valeant Pharmaceuticals International, Inc. in Ontario and the Statement of Claim has been amended. The Ontario Fresh as Amended Statement of Claim is available here. The consolidated claim in Ontario has been temporarily stayed pending further order of the court. A class action on behalf of investors in Valeant is proceeding in Quebec. The motion for certification and for leave to proceed with statutory claims under the Securities Act is scheduled for April 24-27, 2017.
